Experimental structure based drug design (SBDD) applications for anti-leishmanial drugs: A paradigm shift?

1. Marín, M.
2. López, M.
3. Gallego-Yerga, L.
4. Álvarez, R.
5. Peláez, R.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1002/MED.22005 GOOGLE SCHOLAR lock_openOpen access editor